Funding for this research was provided by:
Vetenskapsrådet
Cancerfonden
Barncancerfonden
Hjärnfonden
Karolinska Institutet
Radiumhemmets Forskningsfonder
Article History
Received: 23 January 2023
Revised: 24 March 2023
Accepted: 28 March 2023
First Online: 8 April 2023
Competing interests
: JF is current employee of Cambridge Epigenetix and holds stock options. BJ is co-founder of CERVO Therapeutics AB.